Golden has been acquired by ComplyAdvantage.Read about it here ⟶

PEP-Therapy

Developer of innovative peptides designed to offer targeted therapies for severe diseases, with an initial focus on oncology. The company's peptides are active compounds that penetrate cells and block relevant intracellular protein interactions that offer intracellular delivery of targeted therapies.

Overview Structured Data Issues Contributors Activity

Is a

Company attributes

Industry

Biomedical engineering

0

0

...

Location

0

0

CEO

Antoine Prestat

0

Founder

Antoine Prestat

0

Pitchbook URL

pitchbook.com/profiles...112264-03

Number of Employees (Ranges)

11 – 50

Email Address

hello.pep@pep-therapy.com0

Phone Number

+331839713350

Number of Employees

120

Full Address

Pépinière Paris Santé Cochin 29 rue du Faubourg Saint Jacques 75014 Paris – France0

Pépinière Genopole Entreprises 4 rue Pierre Fontaine 91058 Evry Cedex – France0

Investors

Magna Capital Partners

0

Doorway Capital

0

Seventure Partners

Founded Date

2014

0

Total Funding Amount (USD)

3,100,000

Latest Funding Round Date

July 20, 2021

Competitors

0

Board of Directors

Antoine Prestat

0

Latest Funding Type

Country

Other attributes

Latest Funding Round Amount (USD)

3,100,000

Public/Private

Private0

No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more companies like PEP-Therapy

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.

Open Query Tool

Golden Query Tool